Post Title

A #SciencePerspective from earlier this year highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders.

Read more:
https://scim.ag/4gmyfMY